Biomarin Pharmaceutical Inc at Goldman Sachs Healthcare CEOs Unscripted: A View from the Top Transcript
Great. Well, good morning, everyone. Thanks for joining us. I'm Salveen Richter. I cover the biotechnology sector at Goldman Sachs. It's a good day to have the Chairman and CEO of BioMarin with us, Jean-Jacques Bienaimé.
Questions & Answers
And with that, J.J., maybe starting the first question. As we enter the new decade, looking back, how has BioMarin evolved as a company? What can we really expect here over the next 10 years?
©,-&
So good morning, everyone. It's pleasure to be here. Thank you, Salveen, for having us.
[With this], we've known each other for quite a while. I think you've been following BioMarin almost since I joined the company or a couple of years later. So I joined the company 14.5 years ago. So if you look back,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
